MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0040260
Hillon Pharmaceuticals Private Limited
Hillon Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹38.68 Lakh
▲ 35% YoY
Net profit · FY 2024
₹57,027
Net margin 1.5%
EBITDA · FY 2024
₹2.02 Lakh
EBITDA margin 5.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹12.7 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Hillon Pharmaceuticals Private Limited
Data last updated:
Hillon Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 07 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC355427. Its GSTIN is 20AAECH2757G1ZX (Jharkhand).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Pankaj Kumar and Deepak Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Desk No 2 2nd/Floor Back Side Office No – 4 Master Space Plot No – 27, Kh/Mustatil No – 154 Killa No – 19/2 Uggarsain Park Dichaon Road Najafgarh Street No – 2, New Delhi, Delhi, India – 110043.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.68 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹57,027 (net margin 1.5%) and EBITDA of ₹2.02 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 77% over five years.
As per MCA filings, the company has open charges of ₹12.7 Lakh on record.
Hillon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0040260). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2017PTC355427
Registration Number 355427
Incorporation Date 07 August 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0040260
CIN history
Hillon Pharmaceuticals has one previous CIN (Corporate Identification Number): U51909JH2017PTC010328. The current CIN is U51909DL2017PTC355427, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909DL2017PTC355427 | Current |
| U51909JH2017PTC010328 | Previous |
Recognitions & Rankings of Hillon Pharmaceuticals
Contact details
Hillon Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDesk No 2 2nd/Floor Back Side Office No – 4 Master Space Plot No – 27, Kh/Mustatil No – 154 Killa No – 19/2 Uggarsain Park Dichaon Road Najafgarh Street No – 2, New Delhi, Delhi, India – 110043
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Hillon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Hillon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hillon Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hillon Pharmaceuticals Private Limited, buy the company report.
Financials of Hillon Pharmaceuticals Private Limited
FY 2025 filings availableHillon Pharmaceuticals Private Limited reported revenue of ₹38.68 Lakh (up 35% YoY) for FY 2024.
Revenue · FY 2024
₹38.68 Lakh ▲ 35%
Net profit · FY 2024
₹57,027 margin 1.5%
EBITDA · FY 2024
₹2.02 Lakh margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 47%
5 years · compounded
▲ 77%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 76%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 77% over five years, including 35% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,027 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hillon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hillon Pharmaceuticals Private Limited
Hillon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Also directs: White Tie Corporation LLP, Kumar Lal & Sharma LLP | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Deepak Kumar Singh | Director | 07 Aug 2017 | 9 Years 2 Months | Current |
| Jwala Kumar Singh | Director | 07 Aug 2017 | 9 Years 2 Months | Current |
Auditor
Hillon Pharmaceuticals Private Limited is audited by NIDHI AGARWAL for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIDHI AGARWAL | FY 2018 | 427849 |
Shareholding
The shareholding of Hillon Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Hillon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.7 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2022 | 100657363 | Indian Bank | ₹10 Lakh | Open | |
| 08 Sep 2021 | 100492477 | Hdfc Bank Limited | ₹2.7 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Hillon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hillon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hillon Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAECH2757G1ZX | Jharkhand | Active | 19 Jan 2018 |
To see the full GST registrations and return filing status of Hillon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hillon Pharmaceuticals Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Pankaj Kumar ceased to be Additional Director on 29 Sep 2023.
AGM
Hillon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hillon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Pankaj Kumar ceased to be Additional Director.
Appointed
Pankaj Kumar was appointed as Director.
Charges
A charge with Indian Bank amounted to Rs. 10.00 Lakh with Charge ID 100657363 was registered on 05 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.70 Lakh with Charge ID 100492477 was registered on 08 Sep 2021.
Appointed
Deepak Kumar Singh was appointed as Director.
Appointed
Jwala Kumar Singh was appointed as Director.
Incorporation
07 Aug 2017
Hillon Pharmaceuticals Private Limited was registered on 07 Aug 2017 with Roc Delhi & aged 9 years 2 months as per MCA records.
Frequently asked questions
Hillon Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 07 August 2017 (9+ years old) and is registered under CIN U51909DL2017PTC355427.
Hillon Pharmaceuticals has 3 current directors:
- Pankaj Kumar - Director
- Deepak Kumar Singh - Director
- Jwala Kumar Singh - Director
The latest financial statements of Hillon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Hillon Pharmaceuticals is 20AAECH2757G1ZX, registered in Jharkhand.
The CIN (Corporate Identification Number) of Hillon Pharmaceuticals is U51909DL2017PTC355427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hillon Pharmaceuticals was incorporated on 07 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Pankaj Kumar ceased to be Additional Director on 29 Sep 2023. Pankaj Kumar was appointed as Director on 10 Jan 2023. Deepak Kumar Singh was appointed as Director on 07 Aug 2017. Hillon Pharmaceuticals has 4 board changes on record in total.
Yes, Hillon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0040260).
The registered office of Hillon Pharmaceuticals is at Desk No 2 2ndFloor Back Side Office No – 4 Master Space Plot No – 27, KhMustatil No – 154 Killa No – 192 Uggarsain Park Dichaon Road Najafgarh Street No – 2, New Delhi, Delhi, India – 110043.
Hillon Pharmaceuticals operates in the trading industry, in the specialty segment.